CN103442706A - 用于从组织中除去元素的包含巯基的化合物及其制剂 - Google Patents

用于从组织中除去元素的包含巯基的化合物及其制剂 Download PDF

Info

Publication number
CN103442706A
CN103442706A CN2012800121240A CN201280012124A CN103442706A CN 103442706 A CN103442706 A CN 103442706A CN 2012800121240 A CN2012800121240 A CN 2012800121240A CN 201280012124 A CN201280012124 A CN 201280012124A CN 103442706 A CN103442706 A CN 103442706A
Authority
CN
China
Prior art keywords
group
alkyl
hydrogen
carboxyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012800121240A
Other languages
English (en)
Chinese (zh)
Inventor
博伊德·E·黑利
大卫·A·阿特伍德
尼拉德里·N·古普塔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kentucky Research Foundation filed Critical University of Kentucky Research Foundation
Publication of CN103442706A publication Critical patent/CN103442706A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/04Chelating agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D53/00Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
    • B01D53/34Chemical or biological purification of waste gases
    • B01D53/46Removing components of defined structure
    • B01D53/64Heavy metals or compounds thereof, e.g. mercury
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2253/00Adsorbents used in seperation treatment of gases and vapours
    • B01D2253/10Inorganic adsorbents
    • B01D2253/106Silica or silicates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2253/00Adsorbents used in seperation treatment of gases and vapours
    • B01D2253/25Coated, impregnated or composite adsorbents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2257/00Components to be removed
    • B01D2257/60Heavy metals or heavy metal compounds
    • B01D2257/602Mercury or mercury compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2258/00Sources of waste gases
    • B01D2258/02Other waste gases
    • B01D2258/0283Flue gases
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2258/00Sources of waste gases
    • B01D2258/02Other waste gases
    • B01D2258/0283Flue gases
    • B01D2258/0291Flue gases from waste incineration plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Analytical Chemistry (AREA)
  • Environmental & Geological Engineering (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
CN2012800121240A 2011-03-07 2012-01-06 用于从组织中除去元素的包含巯基的化合物及其制剂 Pending CN103442706A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/041,798 2011-03-07
US13/041,798 US8575218B2 (en) 2009-09-28 2011-03-07 Thiol-containing compounds for the removal of elements from tissues and formulations therefor
PCT/US2012/020418 WO2012121798A2 (en) 2011-03-07 2012-01-06 Thiol-containing compounds for the removal of elements from tissues and formulations therefor

Publications (1)

Publication Number Publication Date
CN103442706A true CN103442706A (zh) 2013-12-11

Family

ID=46798686

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012800121240A Pending CN103442706A (zh) 2011-03-07 2012-01-06 用于从组织中除去元素的包含巯基的化合物及其制剂

Country Status (7)

Country Link
US (1) US8575218B2 (https=)
EP (1) EP2683370A4 (https=)
JP (1) JP2014507470A (https=)
CN (1) CN103442706A (https=)
AU (1) AU2012226279A1 (https=)
RU (1) RU2013141994A (https=)
WO (1) WO2012121798A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114642681A (zh) * 2022-03-18 2022-06-21 中国科学院长春应用化学研究所 一种聚合物在顺铂解毒中的应用

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8950583B2 (en) * 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
JP2013505963A (ja) * 2009-09-28 2013-02-21 ユニヴァーシティ オブ ケンタッキー リサーチ ファウンデイション 汚染された環境から元素を除去するチオール含有化合物およびその使用方法
US8426368B2 (en) * 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet
GB2524831A (en) 2014-04-04 2015-10-07 Ermes Medical Company Ltd New pharmaceutical use
GB2526623A (en) 2014-05-30 2015-12-02 Ermes Medical Company Ltd New pharmaceutical use
US9802889B2 (en) 2014-12-02 2017-10-31 Covalent Research Technologies, LLC Solid supported trithiol compounds for removing heavy metals from solution, and filtration systems utilizing the compounds
US20160367620A1 (en) 2015-06-19 2016-12-22 Harry B. Demopoulos Glutathione
WO2018025049A1 (en) 2016-08-05 2018-02-08 Emeramed Limited New use of n,n-bis-2-mercaptoethyl isophthalamide
MX2021005888A (es) * 2018-11-26 2021-06-23 Procter & Gamble Preparacion farmaceutica solida que contiene acido lipoico y uso de esta.
EP3976233A4 (en) * 2019-05-29 2023-07-26 Alliance for Sustainable Energy, LLC SEQUESTRATION COMPOSITIONS AND MATERIALS
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use
WO2026037909A1 (en) 2024-08-16 2026-02-19 Emeramed Limited N,n-bis-2-mercaptoethyl isophthalamide for use in the treatment of pain
GB202413573D0 (en) 2024-09-13 2024-10-30 Emeramed Ltd New pharmaceutical use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) * 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
US20100227812A1 (en) * 2008-12-06 2010-09-09 Haley Boyd E Method of supplementing the diet and ameliorating oxidative stress
CN102612511A (zh) * 2009-09-28 2012-07-25 肯塔基大学研究基金会 用于从污染的环境中去除元素的含巯基化合物及其使用方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039446A (en) 1972-06-28 1977-08-02 Sumitomo Chemical Company, Limited Heavy metal-binding agent process
US4281086A (en) 1978-12-11 1981-07-28 The University Of Illinois Foundation Polymer bound multidentate complexes
JPS57102852A (en) 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
DE3174885D1 (en) 1981-02-03 1986-07-31 Ici Plc Process for the extraction of metal values and novel metal extractants
DE3231982A1 (de) 1982-08-27 1984-03-01 Süd-Chemie AG, 8000 München Thiolathaltiges mittel und verfahren zur entfernung von schwermetallionen aus verduennten waessrigen loesungen
US4673562A (en) 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4751286A (en) 1985-11-19 1988-06-14 The Johns Hopkins University Protein label and drug delivery system
US5200473A (en) 1988-03-25 1993-04-06 Jeanneret Gris Gilbert Chelating resins and method for their use in the extraction of metal ions
US4969995A (en) 1988-08-26 1990-11-13 The United States Of America As Represented By The United States Department Of Energy Removal of metal ions from aqueous solution
US5073575A (en) 1988-08-26 1991-12-17 The Regents Of The University Of California Cadmium ion-chelating synthetic polymers and process thereof
US5173470A (en) 1991-08-09 1992-12-22 Brigham Young University Compositions and processes for removing, separating and concentrating desired ions from solutions using sulfur and aralkyl nitrogen containing ligands bonded to inorganic supports
US5494935A (en) 1992-01-17 1996-02-27 University Of Utah Research Foundation Methods for oral decorporation of metals
SE508881C2 (sv) 1994-03-02 1998-11-16 Ctc Medical Ab Preparat avsett att vid behandling av i tänder befintliga amalgamfyllningar och/eller vid inserering av nya amalgamfyllningar hämma frisättning av Hg från amalgamet och/eller oskadliggöra frisatt Hg
US5615862A (en) 1995-02-02 1997-04-01 Gaudette; Robert M. Metal precipitation composition for treating spent dry film stripping solution
US5766478A (en) 1995-05-30 1998-06-16 The Regents Of The University Of California, Office Of Technology Transfer Water-soluble polymers for recovery of metal ions from aqueous streams
US6126964A (en) 1996-01-04 2000-10-03 Mirus Corporation Process of making a compound by forming a polymer from a template drug
US6896899B2 (en) 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
AU741546B2 (en) 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
US6936729B2 (en) 1998-05-16 2005-08-30 Mirus Bio Corporation Compound containing a labile disulfide bond
US7087770B2 (en) 1998-05-16 2006-08-08 Mirus Bio Corporation Compound containing a labile disulfide bond
EA200301204A1 (ru) 2001-04-30 2004-04-29 Тромсдорф ГмбХ унд Ко.КГ Арцнаймиттель Фармацевтически активные производные нуклеозида, способ их получения, их применение (варианты) и содержащая их фармацевтическая композиция, способ профилактики и/или лечения заболеваний и нарушений млекопитающих (варианты), комбинация лекарственных средств и ее применение (варианты)
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
US20060099239A1 (en) 2002-04-15 2006-05-11 Coleman Henry D Dietary supplement for promoting removal of heavy metals from the body
US6852369B1 (en) 2002-09-05 2005-02-08 University Of Kentucky Research Foundation Method for prevention of solid dissolution through covalent ligand bonding
US20060115555A1 (en) 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
EP1901701A4 (en) 2005-05-24 2012-05-02 David M Ott BODY CARE AND MEDICAL PRODUCTS WITH JOINED SULFUR ORGANIC GROUPS
WO2007041283A2 (en) 2005-09-30 2007-04-12 Patrick James Baggot Maternal chelation for embryo, fetal, and infant benefit
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) * 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
US20100227812A1 (en) * 2008-12-06 2010-09-09 Haley Boyd E Method of supplementing the diet and ameliorating oxidative stress
CN102612511A (zh) * 2009-09-28 2012-07-25 肯塔基大学研究基金会 用于从污染的环境中去除元素的含巯基化合物及其使用方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114642681A (zh) * 2022-03-18 2022-06-21 中国科学院长春应用化学研究所 一种聚合物在顺铂解毒中的应用
CN114642681B (zh) * 2022-03-18 2023-08-29 中国科学院长春应用化学研究所 一种聚合物在顺铂解毒中的应用

Also Published As

Publication number Publication date
US8575218B2 (en) 2013-11-05
US20110160150A1 (en) 2011-06-30
AU2012226279A1 (en) 2013-09-19
EP2683370A4 (en) 2014-10-15
RU2013141994A (ru) 2015-04-20
WO2012121798A2 (en) 2012-09-13
JP2014507470A (ja) 2014-03-27
EP2683370A1 (en) 2014-01-15

Similar Documents

Publication Publication Date Title
CN103442706A (zh) 用于从组织中除去元素的包含巯基的化合物及其制剂
RU2528396C2 (ru) Тиолсодержащие соединения для удаления элементов из загрязненной окружающей среды и способы их применения
Baek et al. Montmorillonite intercalated with glutathione for antioxidant delivery: Synthesis, characterization, and bioavailability evaluation
CN1250293C (zh) 药物复合物
CN102573809B (zh) 结晶方法和生物利用度
CN102188383B (zh) 氨基嘧啶修饰的金纳米颗粒及其制备方法和用途
US20100016270A1 (en) Bridged polycyclic compound based compositions for controlling cholesterol levels
CN110392583A (zh) 改进的杂化的末端树枝状聚合物
CN103316352B (zh) 氧化石墨烯纳米药物载体、抗肿瘤药物及其制备方法
CN105233298A (zh) 一种紫杉醇类磷脂化合物、其药物组合物及应用
MX2008003067A (es) Composicion que comrpende un dendrimero y el uso del mismo para enlazar fosfato.
CN103347849B (zh) 富勒烯с60的均聚氨基酸和杂多氨基酸衍生物、其制备方法和基于该衍生物的药物组合物
US8124364B2 (en) Biotin derivatives
Falynskova et al. Antiviral activity of fullerene-(tris-aminocaproic acid) hydrate against respiratory syncytial virus in HEp-2 cell culture
AU2001274761B2 (en) Reuseable extracorporeal colums loaded with ligand-dibiotin conjugates
CN111247149A (zh) 肾脏靶向的环氧二十碳三烯酸(eet)类似物
WO2018100560A1 (en) Coordination compounds and formulations, preparation methods and use thereof as antiphlogistic agents
EP4146171A1 (en) Therapeutic carbon nanomaterial h2s oxidants for biological polysulfide synthesis
CN104981249B (zh) 抗微生物化合物、它们的合成及其应用
CN103347848A (zh) 水合n-富勒烯氨基酸、其制备方法和以它为基础的药物组合物
CN119894523A (zh) 官能化聚合物的医疗用途
CN111065397A (zh) MEK/PI3K、JAK/MEK、JAK/PI3K/mTOR和MEK/PI3K/mTOR生物学途径的抑制剂和用于改善治疗化合物的淋巴摄取、生物利用度和溶解度的方法
CA2828395A1 (en) Thiol-containing compounds for the removal of elements from tissues and formulations therefor
US20120135959A1 (en) Metalloprotein inhibitors containing nitrogen based ligands
CN107382786B (zh) 寡聚苯撑乙烯化合物及其制备方法和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20131211